BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 14975402)

  • 1. Longer term assessment of photodynamic therapy for intimal hyperplasia: a pilot study.
    Cheung J; Todd M; Turnbull R; Allison B; Mornin L; Carvalho AM; Spurr G; Hsiang Y
    J Photochem Photobiol B; 2004 Feb; 73(3):141-7. PubMed ID: 14975402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventing intimal hyperplasia with photodynamic therapy using an intravascular probe.
    Hsiang Y; Houston G; Crespo T; To E; Todd M; Sobeh M; Bower R
    Ann Vasc Surg; 1995 Jan; 9(1):80-6. PubMed ID: 7703066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxic effect of photodynamic therapy with Photofrin II on intimal hyperplasia.
    Eton D; Shim V; Maibenco TA; Spero K; Cava RA; Borhani M; Grossweiner L; Ahn SS
    Ann Vasc Surg; 1996 May; 10(3):273-82. PubMed ID: 8792996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photodynamic therapy for atherosclerotic stenoses in Yucatan miniswine.
    Hsiang YN; Crespo MT; Machan LS; Bower RD; Todd ME
    Can J Surg; 1994 Apr; 37(2):148-52. PubMed ID: 8156469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photodynamic therapy reduces intimal hyperplasia in prosthetic vascular bypass grafts in a pig model.
    Heckenkamp J; Mellander S; Fogelstrand P; Breuer S; Brunkwall J; Mattsson E
    Eur J Vasc Endovasc Surg; 2007 Sep; 34(3):333-9. PubMed ID: 17513141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective targeting and photodynamic destruction of intimal hyperplasia by scavenger-receptor mediated protein-chlorin e6 conjugates.
    Nagae T; Louie AY; Aizawa K; Ishimaru S; Wilson SE
    J Cardiovasc Surg (Torino); 1998 Dec; 39(6):709-15. PubMed ID: 9972886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Selective hematoporphyrin derivative (HMD) application in arterial vessels using a porous balloon catheter results in equivalent levels as compared to high-dose systemic administration].
    Gonschior P; Erdemci A; Gerheuser F; Gonschior GM; Mack B; Kolbe T; Goetz AE; Höfling B
    Z Kardiol; 1991 Dec; 80(12):738-45. PubMed ID: 1837968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endovascular photodynamic therapy using mono-L-aspartyl-chlorin e6 to inhibit Intimal hyperplasia in balloon-injured rabbit arteries.
    Nagae T; Aizawa K; Uchimura N; Tani D; Abe M; Fujishima K; Wilson SE; Ishimaru S
    Lasers Surg Med; 2001; 28(4):381-8. PubMed ID: 11344521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of the treatment field for the application of vascular photodynamic therapy to inhibit intimal hyperplasia.
    Statius van Eps RG; ChandraSekar NR; Hasan T; LaMuraglia GM
    Photochem Photobiol; 1998 Mar; 67(3):337-42. PubMed ID: 9523533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term survival of patients treated with photodynamic therapy for carcinoma in situ and early non-small-cell lung carcinoma.
    Corti L; Toniolo L; Boso C; Colaut F; Fiore D; Muzzio PC; Koukourakis MI; Mazzarotto R; Pignataro M; Loreggian L; Sotti G
    Lasers Surg Med; 2007 Jun; 39(5):394-402. PubMed ID: 17565719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dosage and timing of Photofrin for photodynamic therapy of intimal hyperplasia.
    Hsiang YN; Crespo MT; Todd ME
    Cardiovasc Surg; 1995 Oct; 3(5):489-94. PubMed ID: 8574531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photodynamic therapy with local photosensitizer delivery inhibits experimental intimal hyperplasia.
    Adili F; Statius van Eps RG; Flotte TJ; LaMuraglia GM
    Lasers Surg Med; 1998; 23(5):263-73. PubMed ID: 9888322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arterial wall strength after endovascular photodynamic therapy.
    Gabeler EE; van Hillegersberg R; Sluiter W; Kliffen M; Statius van Eps RG; Honkoop J; Carlier SG; van Urk H
    Lasers Surg Med; 2003; 33(1):8-15. PubMed ID: 12866116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-pulsed dye laser-mediated photodynamic therapy combined with topical therapy for mild to severe comedonal, inflammatory, or cystic acne.
    Alexiades-Armenakas M
    J Drugs Dermatol; 2006 Jan; 5(1):45-55. PubMed ID: 16468292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The inhibitory effect of antisense phosphorothioate c-myc oligodeoxynucleotide on intimal hyperplasia in rat abdominal aortae after injury with a balloon catheter].
    Wang J; Hu D; Liu K
    Zhonghua Yi Xue Za Zhi; 1998 May; 78(5):388-91. PubMed ID: 10923448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pilot study on light dosimetry variables for photodynamic therapy of Barrett's esophagus with high-grade dysplasia.
    Gill KR; Wolfsen HC; Preyer NW; Scott MV; Gross SA; Wallace MB; Jones LR
    Clin Cancer Res; 2009 Mar; 15(5):1830-6. PubMed ID: 19240171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental research photodynamic effects in perifocal, oedematous brain tissue.
    Goetz C; Hasan A; Stummer W; Heimann A; Kempski O
    Acta Neurochir (Wien); 2002 Feb; 144(2):173-9; discussion 179. PubMed ID: 11862518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photodynamic therapy of esophageal varices: experimental studies in animal veins, and first clinical cases.
    Li CZ; Cheng LF; Wang ZQ; Gu Y
    Endoscopy; 2003 Dec; 35(12):1043-8. PubMed ID: 14648419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous two-photon excitation of photofrin in relation to photodynamic therapy.
    Karotki A; Khurana M; Lepock JR; Wilson BC
    Photochem Photobiol; 2006; 82(2):443-52. PubMed ID: 16613497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Photodynamic therapy in cardiac and vascular surgery].
    Nigri GR; Brini C; LaMuraglia GM; Vietri F
    G Chir; 2002; 23(8-9):301-6. PubMed ID: 12564301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.